Tissue Repair Ltd (ASX:TRP)
Australia · Delayed Price · Currency is AUD 0.1550
0.00 (0.00%)
Mar 3, 2026, 3:43 PM AEST
Tissue Repair Market Cap
Tissue Repair has a market cap or net worth of 9.37 million as of March 3, 2026. Its market cap has decreased by -41.51% in one year.
Market Cap
9.37M
Enterprise Value
1.08M
Revenue
3.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since November 18, 2021, Tissue Repair's market cap has decreased from 42.02M to 9.37M, a decrease of -77.70%. That is a compound annual growth rate of -29.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 9.37M | -59.74% |
| Dec 30, 2025 | 23.28M | 37.50% |
| Dec 31, 2024 | 16.93M | 27.27% |
| Dec 29, 2023 | 13.30M | -4.35% |
| Dec 30, 2022 | 13.91M | -57.80% |
| Dec 31, 2021 | 32.95M | -21.58% |
| Nov 18, 2021 | 42.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 20.28M |
| Neurotech International | 16.85M |
| AdAlta | 10.20M |
| Bio-Gene Technology | 10.07M |
| Invex Therapeutics | 9.39M |
| Immuron | 9.11M |
| Biotron | 8.11M |
| Vectus Biosystems | 7.21M |